跳至主要内容
临床试验/NL-OMON29401
NL-OMON29401招募中不适用

Diabetying & lifestyle as medicine programme for people with diabetes type II in primary care – an implementation pilot

TNO0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
16

研究概览

简要总结

not applicable

研究设计

研究类型
Interventional

入排标准

入选标准

  • •Patient is newly diagnosed with T2D
  • •-Patient is about to start Metformin
  • •-Patient is about to start with a second oral drug (like SU-derivates)
  • •-Patient is about to start with an injectable drug (Insulin or GLP-1)
  • •Besides that, the patients should meet the following inclusion criteria:
  • •-Aged between 30-80 years
  • •-Have a BMI between 25-35 kg/m-2
  • •-Willing and able to sign the informed consent form
  • •-Able to fill in the 360-degree questionnaire which is in Dutch
  • •-Able to work with computers (e.g. for filling out questionnaires).

排除标准

  • •-Dialysis patients
  • •-Possible limiting personal circumstances (e.g. unemployed, illness in the family, dept restructuring)
  • •-Patients under treatment of a psychiatrist
  • •-Incapacitated patients
  • •-Patients in a palliative phase

研究者

发起方
TNO

相似试验

Diabetyping & lifestyle as a medicine | 临床试验